TRALI u ventilovanÃ©ho pacienta â vÃ½skyt, dg., terapie a prevence

More documents

Recommendations

Info

FDA US, Looney M, 2009PG 2010 MB 16
TRANSFUSION RELATED ACUTE LUNG INJUR Y1:50 – 50 000 ??Popovsky USA 1985 pilotní 1:5000Wallis UK 2003 Single center 1:7900Palfi Švédsko 2001 Prospective 1:50SHOT UK 2004 Hemovigilance 1:50000PG 2010 MB 17
Page 1 and 2: TRALI u ventilovaného pacientavýs
Page 3 and 4: Diabetička (75) ICHDKreokluse peri
Page 5 and 6: Wallis JP et al: Single hospital ex
Page 7 and 8: SEPSIS OCCURRENCE IN THE ACUTELY IL
Page 9 and 10: TRICC STUDY : ARDS a plicní edém
Page 11 and 12: Silverboard H, Martin G H:The role
Page 13 and 14: Variabilita plicních potransfuzní
Page 15: Risk of Infection perUnit Transfuse
Page 19 and 20: Úmrtí na možné TRALI a počet T
Page 21 and 22: TRALI• TRALI :patofyziologie a ic
Page 23 and 24: TRALI vs ARDS : odlišnosti• pře
Page 25 and 26: 1) Dárcovské antileukocytární A
Page 27 and 28: Imunogenní(komplement dependentní
Page 29 and 30: N = 74 vs 74 ALI % Kontrolní %Pts
Page 31 and 32: TRALIIMUNOGENNÍNEIMUNOGENNÍ• UP
Page 33 and 34: TRALI• Diagnostika TRALI• Léč
Page 35 and 36: Summary of TRALI reports 2008PG 201
Page 37 and 38: TERAPIE TRALI A KLINICKÝ OUTCOME**
Page 39 and 40: Prevencetlak na dodavatele plasmy -
Page 41 and 42: Prevencebyznys a transfuzní politi

TRALI u ventilovanÃ©ho pacienta â vÃ½skyt, dg., terapie a prevence

Create successful ePaper yourself

Delete template?

Save as template?

TRALI u ventilovanÃ©ho pacienta â vÃ½skyt, dg., terapie a prevence